Plasma Cell Neoplasm
📧 Sign up to get email alerts when something new happens for Plasma Cell Neoplasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-05-11Clinical Trial Update: Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
Bevacizumab was studied in a Phase 2 trial for relapsed or refractory multiple myeloma; the study has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-11Clinical Trial Update: Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
A Phase 1/2 clinical trial update evaluating the combination of Samarium-153 lexidronam pentasodium and bortezomib in relapsed or refractory…
-
CLINICAL_TRIALS trial_result · 2010-10-18Clinical Trial Update: Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple Myeloma [Phase 2]
Phase 2 trial evaluating anti-thymocyte globulin plus melphalan in relapsed multiple myeloma was terminated. Results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-10-01Clinical Trial Update: High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis [Phase 2]
Phase 2 clinical trial evaluating high-dose melphalan followed by peripheral stem cell transplantation in patients with amyloidosis. The stu…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 3]
A Phase 3 clinical trial comparing melphalan with or without Holmium-166 DOTMP, followed by peripheral stem cell transplantation, in patient…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating melphalan and busulfan conditioning followed by donor peripheral stem cell transplantation with tacrolimus and me…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating Holmium-166 DOTMP plus Melphalan and peripheral stem cell transplantation in patients with m…
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma [Phase 2]
Phase II trial evaluating the combination of O6-benzylguanine and carmustine in patients with multiple myeloma. The study has completed.
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: MS-275 in Treating Patients With Hematologic Cancer [Phase 1]
A Phase 1 trial of MS-275 (entinostat) in patients with hematologic cancers, including leukemia, multiple myeloma/plasma cell neoplasms, and…
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 trial of cyclophosphamide followed by bone marrow transplantation for hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-03Clinical Trial Update: Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 1, Phase 2]
This document reports on a Phase 1/2 clinical trial evaluating Holmium-166 DOTMP chemotherapy combined with peripheral stem cell transplanta…